(Q85000324)
Statements
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial (English)
Elizabeth M Berry-Kravis
David Hessl
Barbara Rathmell
Peter Zarevics
Maryann Cherubini
Karen Walton-Bowen
Yi Mu
Danh V Nguyen
Joseph Gonzalez-Heydrich
Paul P Wang
Randall L Carpenter
Mark F Bear
Randi J Hagerman
1 September 2012